Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-17

Clinical Trial Update: A Study to Assess the Efficacy of Omnivirol-Salicylic Acid Combination Therapy for Cutaneous Warts With Emphasis on Persistent Warts [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating Omnivirol-Salicylic Acid combination therapy for cutaneous warts has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omnivirol-Salicylic Acid

Snippet

Sponsor: Universiteit Antwerpen | Conditions: Cutaneous Warts | Phase 2, Phase 3 | Status: COMPLETED